| P&L Statement | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 1467.5 | 2097 | 2117 | 2570 |
| Cost of Material Consumed | 915 | 1593 | 1483 | 1582 |
| Change in Inventory | -51 | -39 | -22 | -89 |
| Gross Margins | 41.12 | 25.89 | 30.99 | 41.91 |
| Employee Benefit Expenses | 108 | 136 | 138 | 290 |
| Other Expenses | 258.7 | 114 | 144 | 390 |
| EBITDA | 236.8 | 293 | 374 | 397 |
| OPM | 16.14 | 13.97 | 17.67 | 15.45 |
| Other Income | 6 | 12 | 13 | 208 |
| Finance Cost | 49 | 78 | 91 | 122 |
| D&A | 86 | 133 | 155 | 199 |
| EBIT | 150.8 | 160 | 219 | 198 |
| EBIT Margins | 10.28 | 7.63 | 10.34 | 7.7 |
| PBT | 101.4 | 91 | 161 | 284 |
| PBT Margins | 6.91 | 4.34 | 7.61 | 11.05 |
| Tax | 30.6 | 32 | 20 | 19 |
| PAT | 70.8 | 59 | 141 | 265 |
| NPM | 4.82 | 2.81 | 6.66 | 10.31 |
| EPS | 51.68 | 43.07 | 102.84 | 30.58 |
Financial Ratios |
2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating Profit Margin | 16.14 | 13.97 | 17.67 | 15.45 |
| Net Profit Margin | 4.82 | 2.81 | 6.66 | 10.31 |
| Earning Per Share (Diluted) | 51.68 | 43.07 | 102.84 | 30.58 |
| Assets | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Fixed Assets | 699 | 975 | 937 | 1383 |
| CWIP | 38 | 20 | 55 | 41 |
| Investments | 35 | 16 | 20 | 22 |
| Trade Receivables | 249.8 | 310 | 301 | 424 |
| Inventory | 350.8 | 352 | 354 | 533 |
| Other Assets | 622.8 | 625 | 627 | 802 |
| Total Assets | 1995.4 | 2298 | 2294 | 3205 |
| Liabilities | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Share Capital | 13.7 | 13.7 | 13.71 | 17.33 |
| FV | 10 | 10 | 10 | 2 |
| Reserves | 887 | 937 | 994 | 1411 |
| Borrowings | 674 | 805 | 754 | 973 |
| Trade Payables | 235 | 268 | 276 | 408 |
| Other Liabilities | 185.7 | 274.3 | 256.29 | 395.67 |
| Total Liabilities | 1995.4 | 2298 | 2294 | 3205 |
| Cash-Flow Statement | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| PBT | 101.9 | 91 | 161 | 284 |
| OPBWC | 243.9 | 301 | 382 | 397 |
| Change in Receivables | -119.3 | -44 | 4.45 | -23 |
| Change in Inventories | -145 | 27 | -1.25 | -133 |
| Change in Payables | 206.1 | 35 | 5.72 | 40 |
| Other Changes | 100.7 | 53.3 | -12.92 | 39 |
| Working Capital Change | 42.5 | 71.3 | -4 | -77 |
| Cash Generated From Operations | 286.4 | 372.3 | 378 | 320 |
| Tax | -42 | -27 | -26 | 24 |
| Cash Flow From Operations | 244.4 | 345.3 | 352 | 344 |
| Purchase of PPE | -145.4 | -172 | -189 | -253 |
| Sale of PPE | 5 | 6.4 | 67 | 1.6 |
| Cash Flow From Investment | -611.6 | -380 | -149 | -738 |
| Borrowing | -102.5 | 147 | -25 | 209 |
| Dividend | -22.6 | -15 | -88 | -72 |
| Equity | 0 | 0 | 0 | 0 |
| Others From Financing | 493.4 | -97 | -144 | 346 |
| Cash Flow from Financing | 368.3 | 35 | -257 | 483 |
| Net Cash Generated | 1.1 | 0.3 | -54 | 89 |
| Cash at the Start | 0.3 | 1.1 | 78 | 24 |
| Cash at the End | 1.4 | 1.4 | 24 | 113 |